The Common Fund’s Cellular Senescence Network (SenNet) Program was established to comprehensively identify and characterize the differences in senescent cells across the body, across various states of human health, and across the lifespan. SenNet will provide publicly accessible atlases of senescent cells, the differences among them, and the molecules they secrete, using data collected from multiple human and model organism tissues. To identify and characterize these rare cells, SenNet will develop innovative tools and technologies that build upon previous advances in single cell analysis, such as those from the Common Fund’s Human Biomolecular Atlas Program and Single Cell Analysis Program. Lastly, SenNet aims to unite cellular senescence researchers by developing common terms and classifications for senescent cells.
New Members: Please make sure you register for an account on SenNet and direct all questions to help@sennetconsortium.org.
You can also visit our Frequently Asked Questions page.
News
Collection of Articles Reports Adances in Building Cellular Organization Maps of the Human Body
NIH launches program to map a rare type of non-dividing cells implicated in human health and disease
Molecular Atlas of Senescent Cells Could Chart Way to Therapies for Age-Related Diseases and Cancer
Pitt teams tapped to develop ‘Google Maps’ of cells important in aging
$125 Million in Grants to Study Cellular Aging to Be Coordinated from Pittsburgh
CMU CompBio Researchers Take Leading Roles in NIH SenNet Program
Buck Institute awarded $12.7 million from NIH to join SenNet, Cellular Senescence Network
$7.5 million to study elusive cell type important in aging, cancer, other diseases
Senescent Cell Tissue Mapping Will Facilitate Study of Aging and Chronic Diseases